Fredun Pharmaceuticals Ltd. - Research Center
539730 FREDUN Group (XT) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Sep ' 19 | |
|---|---|---|---|---|---|
| Sales | 116.97 | 122.57 | 99.17 | 45.33 | 60.22 |
| Operating profit | 8.89 | 6.24 | 4.83 | 2.65 | 4.25 |
| Interest | 3.77 | 2.97 | 1.69 | 1.68 | 2.21 |
| Gross profit | 6.90 | 6.78 | 3.98 | 2.98 | 2.04 |
| EPS (Rs) | 9.20 | 9.40 | 5.43 | 2.16 | 2.78 |
Half yearly
results in details
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Sep ' 19 | |
|---|---|---|---|---|---|
| Other income | 1.77 | 3.51 | 0.84 | 2.01 | - |
| Stock adjustment | -2.01 | 23.55 | -3.40 | 6.21 | 7.01 |
| Raw material | 93.41 | 93.81 | 82.65 | 26.83 | 40.11 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 4.92 | -15.95 | 4.53 | 4.06 | 3.65 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 11.76 | 14.92 | 10.56 | 5.57 | 5.20 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.38 | 1.13 | 1.02 | 0.96 | 0.93 |
| Taxation | 1.42 | 1.48 | 0.79 | - | - |
| Net profit / loss | 4.10 | 4.17 | 2.17 | 0.86 | 1.11 |
| Extra ordinary item | - | - | - | -1.16 | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 4.45 | 4.43 | 3.99 | 3.99 | 3.99 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 7.60 | 5.09 | 4.87 | 5.85 | 7.06 |
| GPM (%) | 5.81 | 5.38 | 3.98 | 6.30 | - |
| NPM (%) | 3.45 | 3.31 | 2.17 | 1.82 | - |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis